Our Public pillar comes to life through tangible results. Every figure reflects our commitment to patients, healthcare professionals, and industrial sovereignty.

Key figures:

  • 9,38/10 satisfaction score for the Gastro Days in Europe
  • 60 000 Healthcare professionals visited
  • 15 million euros invested to centralize Meteospasmyl’s global production at our Dammarie-les-Lys site
  • 2,5 million euros invested to relocate Colchicine production to Bourgogne, France
  • 30 million euros in industrial investments planned over the next three years

Behind these figures lies a shared ambition: to improve patient care, advance scientific knowledge, and strengthen our industrial footprint in France.

Discover our poster dedicated to the Public pillar and the commitments shaping our future.

No comments yet, be the first to comment.

Залишити відповідь